Gram-Negative "Superbugs" Meeting 2013
 
Conference Committee
GRAM NEGATIVE SUPERBUGS MEETING - COMMITTEE MEMBERS

Professor David Paterson
Professor of Medicine
The University of Queensland Centre for Clinical Research (UQCCR)
Meeting Chair Person (Convenor)

David L. Paterson is a Professor of Medicine at The University of Queensland Centre for Clinical Research (UQCCR) as well as Consultant Infectious Diseases Physician, Consultant Microbiologist and Medical Advisor for the Centre for Healthcare Related Infection Surveillance and Prevention (CHRISP).

Prof Paterson received his medical degree and PhD from The University of Queensland. In 2007, Professor Paterson returned to Brisbane after spending ten years at The University of Pittsburgh School of Medicine. He is the author of more than 270 peer-reviewed publications and more than 30 book chapters. He is a regularly invited speaker at national and international conferences and has lectured in 27 countries.

His research interests include the study of the molecular and clinical epidemiology of infections with antibiotic resistant organisms. The focus of this work is the translation of knowledge into optimal prevention and treatment of these infections.


Dr. Yohei Doi
Assistant Professor of Medicine
University of Pittsburgh

Dr. Yohei Doi graduated from Nagoya University School of Medicine in Nagoya, Japan. After training in internal medicine at Anjo Kosei Hospital near Nagoya, he joined the National Institute of Infectious Diseases in Tokyo, Japan, as a staff researcher. During this period, he worked on characterization of novel antimicrobial resistance mechanisms in Gram-negative pathogens, including 16S ribosomal RNA methyltransferases and extended-spectrum AmpC beta-lactamses, under the mentorship of Dr. Yoshichika Arakawa. He then moved to the United States in 2003 to pursue further clinical training, completing residency in categorical medicine at St. Luke’s Roosevelt Hospital Center in New York City. In 2005, he joined the University of Pittsburgh as a fellow, where he received training in clinical infectious diseases as well as clinical and translational research under the mentorship of Dr. David Paterson. Dr. Doi serves as an assistant professor of medicine at the University of Pittsburgh since 2008. He has published over eighty articles in peer-reviewed journals and has mentored twenty students and trainees in his laboratory. His current research interests include the epidemiology of beta-lactamase-producing Escherichia coli, mechanisms of multidrug resistance in Acinetobacter baumannii and analysis of plasmids conferring multidrug resistance in various gram-negative species.


Associate Professor Anton Peleg
Staff Specialist in Infectious Diseases at the Alfred Hospital and
Principal Investigator in the Dept of Microbiology at Monash University, Melbourne, Australia

Associate Professor Anton Peleg is a staff specialist in Infectious Diseases at the Alfred Hospital, and a Principal Investigator in the Dept of Microbiology at Monash University, Melbourne, Australia. He completed his infectious diseases clinical training in Australia in 2005 and then went to the USA for four years, first working at the University of Pittsburgh Medical Center in the area of transplant infectious diseases, and then at the Harvard-affiliated hospitals in Boston; Beth Israel Deaconess Medical Center and Massachusetts General Hospital. He completed a Masters of Public Health at Harvard School of Public Health, and also completed a PhD in Infectious Diseases and Microbiology. His research interests are in hospital-acquired infections, antibiotic resistance and mechanisms of pathogenesis, and he has over 50 publications. He returned to Australia in 2010 and is a Chief Investigator on multiple Australian National Health and Medical Research Council Project Grants that focus on Acinetobacter baumannii, Staphylococcus aureus and Candida albicans. He is also an active clinician working in the area of hospital-acquired infections and transplant infectious diseases. He is a committee member of the Clinical Research Network of the Australasian Society of Infectious Diseases and the Taskforce Against Multidrug-resistant Gram-negative Bacteria for the Australian Commission on Safety and Quality in Healthcare. He has received numerous national and international awards for his advanced research and contribution to Infectious Diseases and Microbiology.    


Dr Joshua Freeman
Clinical Microbiologist at Auckland City Hospital

Dr Freeman is a Clinical Microbiologist at Auckland City Hospital and an honorary academic at the University of Auckland School of Molecular Medicine and Pathology. He is also the Clinical Lead of Hand Hygiene New Zealand; a national quality improvement programme initiated in 2011 that aims to improve hand hygiene practice in New Zealand hospitals. Prior to his current roles, Dr Freeman worked as a Research Fellow for the Duke Infection Control Outreach Network (DICON) in the Department of Infection Control and Hospital Epidemiology at Duke University Medical Centre. Since 2007, Dr Freeman has co-authored over 30 peer-reviewed papers, letters and online educational monographs relating to susceptibility testing and diagnostics; the prevention of healthcare-associated infections; and the epidemiology of antibiotic resistant pathogens in New Zealand and overseas. Particular areas of research interest include the molecular and clinical epidemiology of antibiotic resistant Enterobacteriaceae, their mechanisms of transmission, and the evaluation of infection control measures to minimise their clinical impact.
 
 
  Professor Jon Iredell
Physician and Microbiologist at Westmead Hospital

Professor Jon Iredell is a physician and microbiologist based at Westmead Hospital and University of Sydney, with a particular interest in intensive care and the infections that complicate or require it. NHMRC currently funds research in bacterial genetics and epidemiology and in translational diagnostics with particular relevance to critical infection. He also runs the NHMRC Centre for Research Excellence in Critical Infection, which focuses on research on the epidemiology and diagnosis of severe infection, including septic shock, severe pneumonia and encephalitis.